> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Meeting on Study Disruptions During Emergencies
- URL: https://www.fdaweb.com/meeting-on-study-disruptions-during-emergencies/
- Published: 2023-08-03T12:00:00.000Z
- Updated: 2026-09-14T18:48:22.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5155015

*Federal Register* notice: FDA is announcing a 10/18-19 public meeting entitled “Mitigating Clinical Study Disruptions During Disasters and Public Health Emergencies.” The meeting will satisfy the mandate of the Food and Drug Omnibus Reform Act of 2022 (FDORA) to convene a public meeting on clinical study flexibilities initiated in response to the Covid–19 pandemic. The meeting is supported by a cooperative agreement between the agency and the Clinical Trials Transformation Initiative (CTTI) to bring the clinical research community together to discuss a variety of topics related to mitigating disruptions of clinical studies of medical products during disasters and public health emergencies. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2023-08-03/pdf/2023-16544.pdf?ref=fdaweb.com).